May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?

被引：16

作者：

Turriziani, O

Di Marco, P

Antonelli, G

Dianzani, F

机构：

[1] Univ La Sapienza, Dept Expt Med & Pathol, I-00185 Rome, Italy

[2] Libera Univ, Rome, Italy

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 02期

关键词：

D O I：

10.1128/AAC.44.2.473-474.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：473 / 474

页数：2

共 6 条

[1]

Cole S P, 1996, Cancer Treat Res, V87, P39

[2] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].

Kim, RB ;

Fromm, MF ;

Wandel, C ;

Leake, B ;

Wood, AJJ ;

Roden, DM ;

Wilkinson, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294

[3] HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter [J].

Lee, CGL ;

Gottesman, MM ;

Cardarelli, CO ;

Ramachandra, M ;

Jeang, KT ;

Ambudkar, SV ;

Pastan, I ;

Dey, S .

BIOCHEMISTRY, 1998, 37 (11) :3594-3601

[4] Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters [J].

Srinivas, RV ;

Middlemas, D ;

Flynn, P ;

Fridland, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3157-3162

[5] Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells [J].

Washington, CB ;

Duran, GE ;

Man, MC ;

Sikic, BI ;

Blaschke, TF .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (03) :203-209

[6]

YUSA K, 1989, CANCER RES, V49, P5002

← 1 →